Enrollment snafus implicated in psychiatric drug trials; FDA gives orphan nod to Xoma;

Conversations on Twitter :

  • "Is there an app for that?" Thought-provoking post & discussion on how oncologists sort through new anticancer drugs.
  • Aging fathers & rising mutations: Nature paper sparks discussion ranging from Hugh Hefner's offspring to schizophrenia prevalence.

 @FierceBiotech: From FierceCRO: Researchers bristle at India's proposed trial reforms. Story | Follow @FierceBiotech

 @JohnCFierce: Fate Therapeutics raised a bit more than $9M for their stem cell work. Run by biotech vet Bill Rastetter. More | Follow @JohnCFierce

 @RyanMFierce: J&J is heading into Phase III with a new RA drug, add on big inflammation biz, not sure what hopes are for this one. More | Follow @RyanMFierce

> Are trials for psychiatric drugs enrolling the wrong patients? Report

> The CEO of the biotech company Tigenix sounded upbeat about the prospects of nailing down a partner for CX601 by the end of the year. Story

> The Oregon Translational Research and Development in Portland faces a major decision next month when state offices make a call on providing $2 million to help keep the organization vital in driving biotech growth in the region. More

> The FDA awarded the biotech Xoma orphan drug status for its lead drug candidate gevokizumab for treating an eye ailment called uveitis. Article

> Samsung, known widely for its consumer electronics, has jumped into the genome analysis game. Item

> EU inspectors green-lighted Alexza's plan after the FDA raised concerns about the facility. Article

Pharma News

 @FiercePharma: Thumbs up from HSBC on India's pharma sector. Dr Reddy's, Sun Pharma, Cipla are its faves--Reuters. | Follow @FiercePharma

> FDA bears greater ethical burden in post-marketing trials, NEJM says. Article

> Indian sales reps strike to demand strict drug-promo rules. More

> AZ's Nexium tops Q2 sales ranks, with BMS' Abilify on its heels. Report

> Pfizer, Mylan plan joint attack on Japanese generics market. Story

Medical Device News

@FierceMedDev: The FBI arrested two former ArthoCare execs, charging them with defrauding investors of $400M. Release | Follow @FierceMedDev

 @MarkHFierce: Faridabad in India is becoming a huge hub for medical device and equipment manufacturers. More | Follow @MarkHFierce

 @DamianFierce: CareFusion's fourth Class I recall of the summer deals with is Alaris infusion pumps. Article | Follow @DamianFierce

> Varian Medical chooses South Korea for overseas subsidiary. News

> Devicemakers cautiously optimistic after meeting with FDA chief. Story

> GI Dynamics gains FDA nod for obesity device pivotal trial. Item

> CareFusion hit with another Class I recall over pump. News

Vaccines News

> Bavarian Nordic in peril if U.S. nixes smallpox vaccine order. Report

> Labs, NIH zero in on painless vaccine technology. More

> NIAID provides $7.8M in grants for HIV research. Article

> PATH Malaria Vaccine Initiative creates reference lab. Item

> Merck's Varivax slashes U.S. chickenpox cases. Story

Pharma Manufacturing News

> India's Faridabad builds manufacturing mass. Story

> EU inspectors give Alexza plant the approval that FDA denied it. News

> West tapping growth in India, Asia. More

> Forfeiture of 27 ANDAs is a small piece of Ranbaxy penalties. Item

And Finally… Researchers used DNA sequencing in a battle to thwart a killer strain of the bug Klebsiella pneumonia in an NIH hospital. Article (sub. req.)